Aurubis (NDA) Given a €88.00 Price Target at Hauck & Aufhaeuser
Aurubis (ETR:NDA) received a €88.00 ($104.76) price target from equities researchers at Hauck & Aufhaeuser in a research note issued on Thursday. The brokerage currently has a “buy” rating on the stock. Hauck & Aufhaeuser’s target price points to a potential upside of 23.16% from the stock’s previous close.
Other equities research analysts also recently issued research reports about the company. Goldman Sachs Group set a €54.50 ($64.88) price objective on Aurubis and gave the company a “sell” rating in a report on Monday. Commerzbank set a €65.00 ($77.38) price objective on Aurubis and gave the company a “sell” rating in a report on Wednesday. Baader Bank set a €74.00 ($88.10) price objective on Aurubis and gave the company a “neutral” rating in a report on Wednesday. Warburg Research set a €84.00 ($100.00) price objective on Aurubis and gave the company a “buy” rating in a report on Monday. Finally, Berenberg Bank set a €73.50 ($87.50) price objective on Aurubis and gave the company a “neutral” rating in a report on Wednesday. Six analysts have rated the stock with a sell rating, six have assigned a hold rating and four have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of €71.48 ($85.09).
Aurubis (ETR:NDA) opened at €71.45 ($85.06) on Thursday. Aurubis has a 52 week low of €50.58 ($60.21) and a 52 week high of €79.29 ($94.39).
Aurubis AG engages in the copper concentrate processing, metal recycling, and copper product fabrication activities in Europe, Asia, the United States, and internationally. It operates in two segments, Primary Copper and Copper Products. The company procures and processes copper concentrates; produces and markets exchange-traded copper cathodes; and produces and markets sulfuric acid, iron silicate, precious metals, and specialty products.
Receive News & Ratings for Aurubis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurubis and related companies with MarketBeat.com's FREE daily email newsletter.